FDA.reportPublic FDA data

antihemophilic factor / von Willebrand factor complex, human 1 UNT Injection

RxCUI
1661332
RxNorm name
antihemophilic factor / von Willebrand factor complex, human 1 UNT Injection
Display name
antihemophilic factor / von Willebrand factor complex, human 1 UNT Injection
Full name
antihemophilic factor / von Willebrand factor complex, human 1 UNT Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:59

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125251Wilatevon Willebrand Factor/Coagulation Factor VIII Complex (Human)351(a)Rx2026-09-01
103960Humate-PAntihemophilic Factor/von Willebrand Factor Complex (Human)351(a)Rx2026-09-01
102475AlphanateAntihemophilic Factor/von Willebrand Factor Complex (Human)351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 4 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
5a7aea94-654c-4113-9014-c3137de0a931antihemophilic factor / von Willebrand factor complex, human 1 UNT Injection [PSN] · factor VIII, human 1 UNT / von Willebrand factor, human 1 UNT Injection [SCD] · factor VIII / von Willebrand Factor complex, human 1 UNT Injection [SY]326These highlights do not include all the information needed to use ALPHANATE safely and effectively. See full prescribing information for ALPHANATE. ALPHANATE (ANTIHEMOPHILIC FACTOR/VON WILLEBRAND FACTOR COMPLEX [HUMAN]) Lyophilized Powder for Solution for Intravenous Injection Initial U.S. Approval: 197820250522
a8ef06b8-b041-054e-e58d-fd8a994a8071antihemophilic factor / von Willebrand factor complex, human 1 UNT Injection [PSN] · factor VIII, human 1 UNT / von Willebrand factor, human 1 UNT Injection [SCD] · factor VIII / von Willebrand Factor complex, human 1 UNT Injection [SY]323These highlights do not include all the information needed to use WILATE safely and effectively. See full prescribing information for WILATE. WILATE, von Willebrand Factor/Coagulation Factor VIII Complex (Human) Lyophilized Powder for Solution for Intravenous Injection Initial U.S. Approval: 2009 ----------------------------RECENT MAJOR CHANGES------------------- Indication and Usage (1) 12/2023 Dosage and Administration (2.2, 2.3) 11/202420241119
c5f4b63b-8d8b-45b3-b530-2f1c32a1b852antihemophilic factor / von Willebrand factor complex, human 1 UNT Injection [PSN] · factor VIII, human 1 UNT / von Willebrand factor, human 1 UNT Injection [SCD] · factor VIII / von Willebrand Factor complex, human 1 UNT Injection [SY]316These highlights do not include all the information needed to use HUMATE-P safely and effectively. See full prescribing information for HUMATE-P. HUMATE-P [Antihemophilic Factor/von Willebrand Factor Complex (Human)] Lyophilized Powder for Reconstitution for Intravenous Use Only. Initial U.S. Approval: 198620200817
d0379e0c-bb51-554e-a58b-b2afa60019d4antihemophilic factor / von Willebrand factor complex, human 1 UNT Injection [PSN] · factor VIII, human 1 UNT / von Willebrand factor, human 1 UNT Injection [SCD] · factor VIII / von Willebrand Factor complex, human 1 UNT Injection [SY]312These highlights do not include all the information needed to use Wilate safely and effectively. See full prescribing information for Wilate. Wilate, von Willebrand Factor/Coagulation Factor VIII Complex (Human), Powder for Solution, for Intravenous Use Only. Initial U.S. Approval: 200920100820